Bioengineering: Bioengineering dermo-epidermal skin grafts with blood and lymphatic capillaries

Science Translational Medicine

Volumn 6, Issue 221, 2014, Pages

  Marino, Daniela ^a   Luginbühl, Joachim ^a   Scola, Simonetta ^a   Meuli, Martin ^a   Reichmann, Ernst ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FIBRIN;

ANIMAL; ARTICLE; BIOENGINEERING; CAPILLARY; CELL LINEAGE; CELL SEPARATION; CYTOLOGY; DERMIS; DRUG EFFECT; ENDOTHELIUM CELL; EPIDERMIS; EPITHELIUM CELL; HUMAN; HYDROGEL; LYMPH VESSEL; LYMPHANGIOGENESIS; MALE; METABOLISM; METHODOLOGY; NUDE RAT; PHYSIOLOGY; RAT; SKIN TRANSPLANTATION; TRANSPLANTATION;

ANIMALS; BIOENGINEERING; BIOLOGICAL MARKERS; CAPILLARIES; CELL LINEAGE; CELL SEPARATION; DERMIS; ENDOTHELIAL CELLS; EPIDERMIS; EPITHELIAL CELLS; FIBRIN; HUMANS; HYDROGELS; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MALE; RATS; RATS, NUDE; SKIN TRANSPLANTATION;

EID: 84893874811     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3006894     Document Type: Article

References (45)

1. A. Atala, F. K. Kasper, A. G. Mikos, Engineering complex tissues. Sci. Transl. Med. 4, 160rv12 (2012).
2. S. Böttcher-Haberzeth, T. Biedermann, E. Reichmann, Tissue engineering of skin. Burns 36, 450-460 (2010).
3. H. Bae, A. S. Puranik, R. Gauvin, F. Edalat, B. Carrillo-Conde, N. A. Peppas, A. Khademhosseini, Building vascular networks. Sci. Transl. Med. 4, 160ps23 (2012).
4. A. F. Black, F. Berthod, N. L'Heureux, L. Germain, F. A. Auger, In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent. FASEB J. 12, 1331-1340 (1998).
5. L. Gibot, T. Galbraith, J. Huot, F. A. Auger, A preexisting microvascular network benefits in vivo revascularization of a microvascularized tissue-engineered skin substitute. Tissue Eng. Part A 16, 3199-3206 (2010).
6. D. M. Supp, K. Wilson-Landy, S. T. Boyce, Human dermal microvascular endothelial cells form vascular analogs in cultured skin substitutes after grafting to athymic mice. FASEB J. 16, 797-804 (2002).
7. I. Montaño, C. Schiestl, J. Schneider, L. Pontiggia, J. Luginbühl, T. Biedermann, S. Böttcher-Haberzeth, E. Braziulis, M. Meuli, E. Reichmann, Formation of human capillaries in vitro: The engineering of prevascularized matrices. Tissue Eng. Part A 16, 269-282 (2010).
8. M. Skobe, M. Detmar, Structure, function, and molecular control of the skin lymphatic system. J. Investig. Dermatol. Symp. Proc. 5, 14-19 (2000).
9. R. Gerli, R. Solito, E. Weber, M. Aglianó, Specific adhesion molecules bind anchoring filaments and endothelial cells in human skin initial lymphatics. Lymphology 33, 148-157 (2000).
10. A. Henno, S. Blacher, C. Lambert, A. Colige, L. Seidel, A. Noël, C. Lapière, M. de la Brassinne, B. V. Nusgens, Altered expression of angiogenesis and lymphangiogenesis markers in the uninvolved skin of plaque-type psoriasis. Br. J. Dermatol. 160, 581-590 (2009).
11. R. Kunstfeld, S. Hirakawa, Y. K. Hong, V. Schacht, B. Lange-Asschenfeldt, P. Velasco, C. Lin, E. Fiebiger, X. Wei, Y. Wu, D. Hicklin, P. Bohlen, M. Detmar, Induction of cutaneous delayedtype hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia. Blood 104, 1048-1057 (2004).
12. F. Pedica, C. Ligorio, P. Tonelli, S. Bartolini, P. Baccarini, Lymphangiogenesis in Crohn's disease: An immunohistochemical study using monoclonal antibody D2-40. Virchows Arch. 452, 57-63 (2008).
13. A. Saaristo, T. Tammela, A. Farkkilā, M. Kärkkäinen, E. Suominen, S. Yla-Herttuala, K. Alitalo, Vascular endothelial growth factor-C accelerates diabetic wound healing. Am. J. Pathol. 169, 1080-1087 (2006).
14. E. Kriehuber, S. Breiteneder-Geleff, M. Groeger, A. Soleiman, S. F. Schoppmann, G. Stingl, D. Kerjaschki, D. Maurer, Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J. Exp. Med. 194, 797-808 (2001).
15. Y. K. Hong, N. Harvey, Y. H. Noh, V. Schacht, S. Hirakawa, M. Detmar, G. Oliver, Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev. Dyn. 225, 351-357 (2002).
16. J. T. Wigle, N. Harvey, M. Detmar, I. Lagutina, G. Grosveld, M. D. Gunn, D. G. Jackson, G. Oliver, An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 21, 1505-1513 (2002).
17. K. Hida, Y. Hida, D. N. Amin, A. F. Flint, D. Panigrahy, C. C. Morton, M. Klagsbrun, Tumorassociated endothelial cells with cytogenetic abnormalities. Cancer Res. 64, 8249-8255 (2004).
18. T. A. Fong, L. K. Shawver, L. Sun, C. Tang, H. App, T. J. Powell, Y. H. Kim, R. Schreck, X. Wang, W. Risau, A. Ullrich, K. P. Hirth, G. McMahon, SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res. 59, 99-106 (1999).
19. S. Levenberg, J. Rouwkema, M. Macdonald, E. S. Garfein, D. S. Kohane, D. C. Darland, R. Marini, C. A. van Blitterswijk, R. C. Mulligan, P. A. D'Amore, R. Langer, Engineering vascularized skeletal muscle tissue. Nat. Biotechnol. 23, 879-884 (2005).
20. N. C. Rivron, J. J. Liu, J. Rouwkema, J. de Boer, C. A. van Blitterswijk, Engineering vascularised tissues in vitro. Eur. Cell. Mater. 15, 27-40 (2008).
21. S. Gupta, Optimal use of negative pressure wound therapy for skin grafts. Int. Wound J. 9 (Suppl. 1), 40-47 (2012).
22. L. Jewell, R. Guerrero, A. R. Quesada, L. S. Chan, W. L. Garner, Rate of healing in skin-grafted burn wounds. Plast. Reconstr. Surg. 120, 451-456 (2007).
23. T. Hitchcock, L. Niklason, Lymphatic tissue engineering: Progress and prospects. Ann. N. Y. Acad. Sci. 1131, 44-49 (2008).
24. L. E. Niklason, J. Koh, A. Solan, Tissue engineering of the lymphatic system. Ann. N. Y. Acad. Sci. 979, 27-34; discussion 35-38 (2002).
25. C. L. Helm, A. Zisch, M. A. Swartz, Engineered blood and lymphatic capillaries in 3-D VEGFfibrin-collagen matrices with interstitial flow. Biotechnol. Bioeng. 96, 167-176 (2007).
26. C. P. Ng, C. L. Helm, M. A. Swartz, Interstitial flow differentially stimulates blood and lymphatic endothelial cell morphogenesis in vitro. Microvasc. Res. 68, 258-264 (2004).
27. C. L. Helm, M. E. Fleury, A. H. Zisch, F. Boschetti, M. A. Swartz, Synergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism. Proc. Natl. Acad. Sci. U.S.A. 102, 15779-15784 (2005).
28. Tt. Dai, Zh. Jiang, Sl. Li, Gd. Zhou, J. D. Kretlow, Wg. Cao, W. Liu, Yl. Cao, Reconstruction of lymph vessel by lymphatic endothelial cells combined with polyglycolic acid scaffolds: A pilot study. J. Biotechnol. 150, 182-189 (2010).
29. K. N. Margaris, R. A. Black, Modelling the lymphatic system: Challenges and opportunities. J. R. Soc. Interface 9, 601-612 (2012).
30. E. Braziulis, T. Biedermann, F. Hartmann-Fritsch, C. Schiestl, L. Pontiggia, S. Böttcher-Haberzeth, E. Reichmann, M. Meuli, Skingineering I: Engineering porcine dermo-epidermal skin analogues for autologous transplantation in a large animal model. Pediatr. Surg. Int. 27, 241-247 (2011).
31. E. Braziulis, M. Diezi, T. Biedermann, L. Pontiggia, M. Schmucki, F. Hartmann-Fritsch, J. Luginbühl, C. Schiestl, M. Meuli, E. Reichmann, Modified plastic compression of collagen hydrogels provides an ideal matrix for clinically applicable skin substitutes. Tissue Eng. Part C Methods 18, 464-474 (2012).
32. E. Reichmann, EuroSkinGraft: Novel generation of skin substitutes to clinically treat a broad spectrum of severe skin defects, FP7/2007-2013 grant agreement no. 279024; http://www.euroskingraft.eu.
33. C. Schiestl, T. Biedermann, E. Braziulis, F. Hartmann-Fritsch, S. Böttcher-Haberzeth, M. Arras, N. Cesarovic, F. Nicolls, C. Linti, E. Reichmann, M. Meuli, Skingineering II: Transplantation of large-scale laboratory-grown skin analogues in a new pig model. Pediatr. Surg. Int. 27, 249-254 (2010).
34. R. V. Shevchenko, S. L. James, S. E. James, A review of tissue-engineered skin bioconstructs available for skin reconstruction. J. R. Soc. Interface 7, 229-258 (2010).
35. Regenicin, Permaderm; http://www.regenicin.com/about/about-permaderm. html.
36. A. Feuerstein, FDA did not approve Regenicin skin graft; http://www.thestreet.com/story/11579041/1/fda-did-not-approve-regenicin-skin- graft.html.
37. A. Alajati, A. M. Laib, H. Weber, A. M. Boos, A. Bartol, K. Ikenberg, T. Korff, H. Zentgraf, C. Obodozie, R. Graeser, S. Christian, G. Finkenzeller, G. B. Stark, M. Héroult, H. G. Augustin, Spheroid-based engineering of a human vasculature in mice. Nat. Methods 5, 439-445 (2008).
38. F. Bruyère, A. Noël, Lymphangiogenesis: In vitro and in vivo models. FASEB J. 24, 8-21 (2010).
39. V. Schacht, M. I. Ramirez, Y. K. Hong, S. Hirakawa, D. Feng, N. Harvey, M. Williams, A. M. Dvorak, H. F. Dvorak, G. Oliver, M. Detmar, T1α/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 22, 3546-3556 (2003).
40. Y. Xu, L. Yuan, J. Mak, L. Pardanaud, M. Caunt, I. Kasman, B. Larrivée, R. Del Toro, S. Suchting, A. Medvinsky, J. Silva, J. Yang, J. L. Thomas, A. W. Koch, K. Alitalo, A. Eichmann, A. Bagri, Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3. J. Cell Biol. 188, 115-130 (2010).
41. G. Cheng, S. Liao, H. KitWong, D. A. Lacorre, E. di Tomaso, P. Au, D. Fukumura, R. K. Jain, L. L. Munn, Engineered blood vessel networks connect to host vasculature via wrapping-and-tapping anastomosis. Blood 118, 4740-4749 (2011).
42. S. Böttcher-Haberzeth, A. S. Klar, T. Biedermann, C. Schiestl, C. Meuli-Simmen, E. Reichmann, M. Meuli, "Trooping the color": Restoring the original donor skin color by addition of melanocytes to bioengineered skin analogs. Pediatr. Surg. Int. 29, 239-247 (2013).
43. T. Biedermann, S. Böttcher-Haberzeth, A. S. Klar, L. Pontiggia, C. Schiestl, C. Meuli-Simmen, E. Reichmann, M. Meuli, Rebuild, restore, reinnervate: Do human tissue engineered dermoepidermal skin analogs attract host nerve fibers for innervation? Pediatr. Surg. Int. 29, 71-78 (2013).
44. D. E. Costea, L. L. Loro, E. A. Dimba, O. K. Vintermyr, A. C. Johannessen, Crucial effects of fibroblasts and keratinocyte growth factor on morphogenesis of reconstituted human oral epithelium. J. Invest. Dermatol. 121, 1479-1486 (2003).
45. K. Kajiya, S. Hirakawa, B. Ma, I. Drinnenberg, M. Detmar, Hepatocyte growth factor promotes lymphatic vessel formation and function. EMBO J. 24, 2885-2895 (2005).